Stock Based Compensation (Tables)

3 Months Ended

Mar. 31, 2022

Share-Based Payment Arrangement [Abstract]

Schedule of stock-based compensation expense stock options and warrants

	Three Months Ended		Three Months Ended
	March 31, 2022		March 31, 2021
Research and development	$	205,809	$	67,279
General and administrative		971,893		963,136
	$	1,177,702	$	1,030,415

Schedule of fair value of employee stock options

	Three Months March 31, 2022
Weighted average exercise price	$	6.90
Weighted average grant date fair value	$	5.20
Assumptions
Expected volatility		96%-97	%
Expected term (in years)		6.3
Risk-free interest rate		1.79%-2.41	%
Expected dividend yield		0.00	%

Schedule of stock option activity

	Number of Shares			Weighted- Average Exercise Prices		Weighted- Average Remaining Contractual Term (In Years)		Intrinsic Value
Outstanding at January 1, 2022		2,893,839		$	6.48		8.05	$	9,932,413
Granted		100,000			6.90		—		—
Cancelled		(17,749	)		11.09		—		—
Outstanding at March 31, 2022		2,976,090		$	6.47		7.87	$	4,435,685
Exercisable at March 31, 2022		1,411,441		$	5.00		7.24	$	3,196,095